• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫非佐辛(N-22)对犬的三个月亚急性经口毒性研究

[Three-month subacute oral toxicity study of mofezolac (N-22) in dogs].

作者信息

Shimpo K, Takeuchi M, Kiguchi M, Iwata M, Nasu Y, Yada H, Yamashita K

机构信息

Safety Research Institute for Chemical Compounds Co., Ltd., Sapporo, Japan.

出版信息

J Toxicol Sci. 1990 Jun;15 Suppl 2:43-76. doi: 10.2131/jts.15.supplementii_43.

DOI:10.2131/jts.15.supplementii_43
PMID:2231795
Abstract

Mofezolac (N-22) is a new developed analgesic and anti-inflammatory agent. A subacute oral toxicity test of N-22 was carried out at dose-levels of 0, 2, 6 and 20 mg/kg/day using male and female beagle dogs. Treatment for 3 months was followed by 1 month recovery period except in the case of both sexes receiving 20 mg/kg/day. The results obtained from the present study were as follows. 1. Observation of general conditions revealed vomiting, sporadic bloody feces, anemia, recumbency and hyposthenia in both sexes receiving 20 mg/kg/day. Anemia or erosion of tongue was observed in each female receiving 6 mg/kg/day. 2. Respectively 3 dogs of both sexes receiving 20 mg/kg/day died during dosing period. In these animals, perforating ulcers were observed in the pars pylorica ventriculi or duodenum, and loss of blood, peritonitis and aggravation of general exhaustion were considered as causes of death. 3. Body weight tended to decrease in both sexes receiving 20 mg/kg/day, and food and water consumption levels decreased in males receiving 2 mg/kg/day or above and females receiving 2 mg/kg/day. 4. Urinalysis demonstrated an increasing tendency for specific gravity of urine and a decreasing tendency for urine volume in males receiving 2 mg/kg/day or above. 5. Hematological examination showed decreases in red blood cell count and Hb concentration in males receiving 2 mg/kg/day or above, and in Ht values in males receiving 6 mg/kg/day or above. 6. Serum biochemical examination revealed decreases in total protein and albumin in both sexes receiving 20 mg/kg/day. 7. There were no remarkable changes in hepatic and renal function, ophthalmological findings or electrocardiogram. 8. In the organ weights, significant decrease in thymus weights was observed in the dead animals receiving 20 mg/kg/day. 9. Pathologically, the dead animals receiving 20 mg/kg/day were found to exhibit peritonitis with perforating ulcers in the pars pylorica ventriculi or duodenum. In the surviving animals of this group, scar ulcers in the pars pylorica ventriculi and small intestine were evident on necropsy, and histopathology revealed neutrophils infiltration and thrombosis in blood vessels in the thickened submucosal stomach tissues. Moreover, localized hepatocyte necrosis and intrasinusoidal cellular infiltration in liver, as well as interstitial cellular infiltration, degeneration and dilatation of the renal tubules in the kidney were observed. In females receiving 6 mg/kg/day, the changes in kidney were similar to those in surviving animals receiving 20 mg/kg/day, and male of the group showed atrophy of thymus.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

莫非佐辛(N - 22)是一种新开发的镇痛抗炎药。使用雄性和雌性比格犬,以0、2、6和20毫克/千克/天的剂量水平进行了N - 22的亚急性口服毒性试验。除了接受20毫克/千克/天剂量的雌雄犬外,治疗3个月后有1个月的恢复期。本研究获得的结果如下。1. 一般状况观察显示,接受20毫克/千克/天剂量的雌雄犬均出现呕吐、散在性血便、贫血、卧地和虚弱。接受6毫克/千克/天剂量的每只雌性犬出现贫血或舌糜烂。2. 接受20毫克/千克/天剂量的雌雄犬各有3只在给药期死亡。在这些动物中,在胃幽门部或十二指肠观察到穿孔性溃疡,失血、腹膜炎和全身衰竭加重被认为是死亡原因。3. 接受20毫克/千克/天剂量的雌雄犬体重均有下降趋势,接受2毫克/千克/天及以上剂量的雄性犬和接受2毫克/千克/天剂量的雌性犬食物和水消耗量下降。4. 尿液分析表明,接受2毫克/千克/天及以上剂量的雄性犬尿液比重有增加趋势,尿量有减少趋势。5. 血液学检查显示,接受2毫克/千克/天及以上剂量的雄性犬红细胞计数和血红蛋白浓度降低,接受6毫克/千克/天及以上剂量的雄性犬血细胞比容值降低。6. 血清生化检查显示,接受20毫克/千克/天剂量的雌雄犬总蛋白和白蛋白均降低。7. 肝肾功能、眼科检查结果或心电图无明显变化。8. 在器官重量方面,接受20毫克/千克/天剂量的死亡动物胸腺重量显著降低。9. 病理检查发现,接受20毫克/千克/天剂量的死亡动物表现为胃幽门部或十二指肠穿孔性溃疡伴腹膜炎。在该组存活动物中,尸检时胃幽门部和小肠可见瘢痕性溃疡,组织病理学显示增厚的胃黏膜下组织血管中有中性粒细胞浸润和血栓形成。此外,在肝脏观察到局部肝细胞坏死和肝血窦内细胞浸润,在肾脏观察到肾小管间质细胞浸润、变性和扩张。接受6毫克/千克/天剂量的雌性犬肾脏变化与接受20毫克/千克/天剂量的存活动物相似,该组雄性犬胸腺萎缩。(摘要截取自400字)

相似文献

1
[Three-month subacute oral toxicity study of mofezolac (N-22) in dogs].莫非佐辛(N-22)对犬的三个月亚急性经口毒性研究
J Toxicol Sci. 1990 Jun;15 Suppl 2:43-76. doi: 10.2131/jts.15.supplementii_43.
2
[Three-month oral subacute toxicity study of mofezolac (N-22) in rats].[莫非唑酸(N - 22)对大鼠的三个月口服亚急性毒性研究]
J Toxicol Sci. 1990 Jun;15 Suppl 2:11-41. doi: 10.2131/jts.15.supplementii_11.
3
[Chronic oral toxicity study of proglumetacin maleate in beagle dogs].马来酸普罗美辛对比格犬的慢性经口毒性研究
J Toxicol Sci. 1987 Feb;12 Suppl 1:1-33. doi: 10.2131/jts.12.supplementi_1.
4
[A 52-week chronic oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethanesulfonate (FUT-187) in dogs].6-脒基-2-萘基 4-[(4,5-二氢-1H-咪唑-2-基)氨基]苯甲酸酯二甲磺酸盐(FUT-187)对犬的52周慢性经口毒性研究
J Toxicol Sci. 1992 Dec;17 Suppl 4:163-99. doi: 10.2131/jts.17.supplementiv_163.
5
[Fifty two-week chronic oral toxicity study of mofezolac (N-22) in rats].莫非唑酸(N - 22)对大鼠的五十二周慢性经口毒性研究
J Toxicol Sci. 1990 Jun;15 Suppl 2:77-109. doi: 10.2131/jts.15.supplementii_77.
6
[Fifty two-week chronic oral toxicity study of mofezolac (N-22) in beagle dogs].
J Toxicol Sci. 1990 Jun;15 Suppl 2:111-49. doi: 10.2131/jts.15.supplementii_111.
7
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
8
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).4,4'-硫代双(6-叔丁基间甲酚)(CAS编号:96-69-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288.
9
[Thirteen-week oral toxicity study of propiverine hydrochloride in dogs].盐酸丙哌维林对犬的13周口服毒性研究
J Toxicol Sci. 1989 Oct;14 Suppl 2:61-109. doi: 10.2131/jts.14.supplementii_61.
10
[A 13-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].新型抗肿瘤药物S-1对大鼠的13周口服重复给药毒性研究
J Toxicol Sci. 1996 Nov;21 Suppl 3:505-26. doi: 10.2131/jts.21.supplementiii_505.